| MO |
Report |
Adj. Diluted EPS (Q2 2026) |
BEAT |
pred ~$1.53 vs. cons $1.495 |
MEDIUM |
| MO |
Report |
Smokeable Net Revenue (Q2 2026) |
IN-LINE |
pred ~$4.65B vs. cons $4.624B |
MEDIUM |
| MO |
Report |
Smokeable OCI Margin (Q2 2026) |
IN-LINE |
pred ~65.3% vs. cons ~64.9% |
MEDIUM |
| MO |
Guide |
FY 2026 Adj. EPS (FY 2026) |
LOWER |
guide midpoint ~$5.64 vs. cons $5.715 |
MEDIUM |
| MO |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.5% |
— |
MEDIUM |
| MO |
Return |
5-day cumulative residual |
-3.5% (FADE) |
FADE — implied H2 cut pulls estimates lower post-print; DTC bid fades after day 1 |
MEDIUM |